ExLibris header image
SFX Logo
Title: SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity
Source:

Nucleic Acids Research [0305-1048] Care, Matthew yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Roukos, Dimitrios H. "Potential of antibody–drug conjugates and novel therapeutics in breast cancer management." OncoTargets and therapy 7 (2014): 491-500. Link to Full Text for this item Link to SFX for this item
2. Perrino, E. "Curative properties of non-internalizing antibody-drug conjugates based on maytansinoids." Cancer research 74.9 (2014): 2569-78. Link to SFX for this item
3. Sibille, G C. "Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders." Genes, brain and behavior 13.1 (2013): 13-24. Link to Full Text for this item Link to SFX for this item
4. Isakoff, Jose J. "Trastuzumab-DM1: Building a Chemotherapy-Free Road in the Treatment of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer." Journal of clinical oncology 29.4 (2010): 351-354. Link to SFX for this item
5. Oh, G. "DNA Modification Study of Major Depressive Disorder: Beyond Locus-by-locus Comparisons." Biological psychiatry 77.3 (2014): 246-255. Link to SFX for this item
6. Rader, C. "Chemically programmed antibodies." Trends in biotechnology 32.4 (2014): 186-197. Link to SFX for this item
7. Neri, D. "Emerging classes of armed antibody therapeutics against cancer." MedChemComm 5.4 (2014): 408-431. Link to Full Text for this item Link to SFX for this item
8. Anderson, John C. "Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma." Blood 123.20 (2014): 3128-3138. Link to SFX for this item
9. Madden, Melissa H. "Circadian pathway genes in relation to glioma risk and outcome." CCC. Cancer causes & control 25.1 (2013): 25-32. Link to Full Text for this item Link to SFX for this item
10. Bernardes, Gonçalo J L L. "Site-specific chemical modification of antibody fragments using traceless cleavable linkers." Nature protocols 8.11 (2013): 2079-2089. Link to SFX for this item
11. Johannsen, M. "The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma." European journal of cancer 46.16 (2010): 2926-2935. Link to SFX for this item
12. Sibille, E. "Differentially expressed genes in major depression reside on the periphery of resilient gene coexpression networks." Frontiers in neuroscience 5 (2011): 95-95. Link to Full Text for this item Link to SFX for this item
13. Sager, J. "Proteins Interacting with Monoamine Transporters: Current State and Future Challenges." Biochemistry 50.34 (2011): 7295-310. Link to Full Text for this item Link to SFX for this item
14. Abraham, V. "Biological considerations and clinical applications of new HER2-targeted agents." Expert review of anticancer therapy 10.9 (2010): 1497-1509. Link to SFX for this item
15. Senter, Stephen D. "Antibody-drug conjugates: targeted drug delivery for cancer." Current opinion in chemical biology 14.4 (2010): 529-537. Link to SFX for this item
16. Burris, Howard A. "Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) -Positive Breast Cancer After Prior HER2-Directed Therapy." Journal of clinical oncology 29.4 (2010): 398-405. Link to SFX for this item
17. Govindan, Serengulam V. "New antibody conjugates in cancer therapy." TheScientificWorldjournal 10.Oct (2010): 2070-2089. Link to Full Text for this item Link to SFX for this item
18. Krop, Ian E. "Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer." Journal of clinical oncology 28.16 (2010): 2698-2704. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.